Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT02204072 2025-07-15

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Phase 1 Completed

120 enrolled 28 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT05169684 2025-06-10

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Phase 2 Terminated

10 enrolled 15 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT05520138 2024-09-27

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Completed

5,506 enrolled 11 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT03016312 2024-08-09

IMbassador250

Phase 3 Completed

759 enrolled 22 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04157088 2023-08-04

DaroAcT

Phase 2 Terminated

30 enrolled 25 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT02057666 2021-04-23

TasQ003

Phase 3 Terminated

146 enrolled 13 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Clinical Trials

QUEST

MAGNITUDE

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Tamarack

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

IMbassador250

DaroAcT

TasQ003